| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Henderson Jeffrey William serves as a Director at HALO and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 1 buy and 19 sells. Those positions are worth an estimated $7.3M at current prices.
Historically, Henderson Jeffrey William's trades have earned a middling insider score of 65/100 across 14 rated trades. Over a 12-month horizon, 46.2% of those trades were profitable, with an average 12-month return of +13.9%.
The biggest single holding is HALO (~$3.8M) as Director. The recent filings there lean toward selling, a net 69,498 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 20,000 | $48.11 | $962,200.00 | -18.5% | -31.0% | -16.4% | |
| Feb 23, 2023 | QCOM Qualcomm Inc/de | Director | Sell | 5,000 | $124.12 | $620,600.75 | -42.7% | -18.4% | +22.7% | |
| Nov 25, 2020 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 24,498 | $40.08 | $981,757.35 | -34.0% | - | - | |
| Nov 10, 2020 | QCOM Qualcomm Inc/de | Director | Sell | 6,000 | $141.10 | $846,602.40 | -83.2% | - | - |